Cyclin D1 expression may be a biomarker for penile cancer

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

A new research paper titled 'Cyclin D1 expression in penile cancer' has been published in Oncotarget.

Cyclin D1 expression may be a biomarker for penile cancer retrieved 15 May 2024 from https://medicalxpress.com/news/2024-05-cyclin-d1-biomarker-penile-cancer.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Sep 16, 2022Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Precision medicine in PET imaging: AI-based attenuation correction for enhanced patient careA new research paper was published in Oncotarget's Volume 15 on May 7, 2024, entitled, 'Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN.'
Source: NewsMedical - 🏆 19. / 71 Read more »

‘Groundbreaking’ DNA tests could ‘spot men most likely to fall victim to under-the-radar prostate cance...Prostate cancer signs & symptoms you should NEVER ignore, with Dr Philippa Kaye
Source: TheSun - 🏆 64. / 61 Read more »

Plant-based diet may aid prostate cancer outcomesConsuming a primarily plant-based diet may be associated with better cancer-specific health outcomes among men with prostate cancer, according to a study published online May 1 in JAMA Network Open.
Source: medical_xpress - 🏆 101. / 51 Read more »

Microbiome researchers challenge the state of the art in colon cancer biomarker discoveryFor the first time, researchers from VIB-KU Leuven, UZ Leuven, Janssen Pharmaceutica and multiple international collaborators have introduced quantitative methods and extensive confounder control to discover microbiome biomarkers in colorectal cancer development.
Source: medical_xpress - 🏆 101. / 51 Read more »

New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patientsA novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment. Utilizing lead-212 (212Pb), the new imaging technique has the potential to change practice and increase access for patients around the world.
Source: medical_xpress - 🏆 101. / 51 Read more »